血清单核细胞趋化蛋白1、基质金属蛋白酶9及胱抑素C水平对脑梗死患者预后的评估价值
作者:
作者单位:

1.邯郸市中心医院神经内科,河北 邯郸 056000;2.安国市医院消化内科,河北 安国 071200;3.安国市医院重症医学科,河北 安国 071200;4.安国市医院普通外科,河北 安国 071200

作者简介:

石小翠(1981-),女,硕士研究生,主治医师,研究方向:脑血管病。Email:zhousy7501@163.com。

通信作者:

基金项目:


Prognostic value of serum levels of monocyte chemotactic protein-1, matrix metalloproteinase-9, and cystatin C in patients with cerebral infarction
Author:
Affiliation:

1.Department of Neurology, Handan Central Hospital, Handan, Hebei 056000, China;2.Department of Gastroenterology, Anguo Hospital, Anguo, Hebei 071200, China;3.Department of Critical Care Medicine, Anguo Hospital, Anguo, Hebei 071200, China;4.Department of General Surgery, Anguo Hospital, Anguo, Hebei 071200, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的 探究血清单核细胞趋化蛋白1(MCP-1)、基质金属蛋白酶9(MMP-9)及胱抑素C(Cys-C)水平对脑梗死患者预后的评估价值。方法 回顾性分析2016年6月—2018年5月收治的173例脑梗死患者的临床资料,根据改良Rankin量表(mRS)评分结果将患者分为预后良好组(MRS≤2分,98例)和预后不良组(MRS>2分,75例),比较两组患者的血清MCP-1、MMP-9、Cys-C水平及美国国立卫生研究院卒中量表(NIHSS)评分,分析MCP-1、MMP-9、Cys-C水平与患者NIHSS评分的相关性;绘制受试者工作特征(ROC)曲线,评估MCP-1、MMP-9及Cys-C对脑梗死患者预后的预测价值。结果 预后不良组患者的血清MCP-1、MMP-9、Cys-C水平及NIHSS评分均高于预后良好组(P <0.05)。Pearson相关性分析结果显示,脑梗死患者的血清MCP-1、MMP-9、Cys-C水平与NIHSS评分均呈正相关(r =0.637、0.579、0.476,均P <0.05)。ROC曲线分析结果显示,MCP-1、MMP-9和Cys-C水平对脑梗死患者预后均有预测价值,其ROC曲线下面积(AUC)分别为0.846、0.764和0.688,对脑梗死患者预后的评估均具有统计学意义(P <0.001)。结论 血清MCP-1、MMP-9和Cys-C水平均可对脑梗死患者的预后进行有效评估,可作为脑梗死患者预后的参考指标。国际神经病学神经外科学杂志, 2021, 48(1): 59-62]

    Abstract:

    Objective To explore the prognostic value of serum levels of monocyte chemotactic protein-1 (MCP-1), matrix metalloproteinase-9 (MMP-9), and cystatin C (Cys-C) in patients with cerebral infarction.Methods We retrospectively analyzed the clinical data of 173 patients with cerebral infarction who were admitted between June 2016 and May 2018. According to the modified Rankin Scale (mRS) score, the patients were divided into good-prognosis group (mRS≤2, 98 cases) and poor-prognosis group (mRS>2, 75 cases). Serum levels of MCP-1, MMP-9, and Cys-C and National Institutes of Health Stroke Scale (NIHSS) score were compared between the two groups. The correlation between MCP-1, MMP-9, and Cys-C levels and NIHSS score was analyzed. A receiver operating characteristic (ROC) curve was used to evaluate the predictive value of MCP-1, MMP-9, and Cys-C for the prognosis of patients with cerebral infarction.Results Serum MCP-1, MMP-9, and Cys-C levels and NIHSS score were significantly higher in the poor-prognosis group than in the good-prognosis group (P <0.05). Pearson correlation analysis showed that serum MCP-1, MMP-9, and Cys-C levels were significantly positively correlated with NIHSS score (r =0.637, 0.579, and 0.476, respectively, all P <0.05). ROC curve analysis showed that MCP-1, MMP-9, and Cys-C levels could predict the prognosis of patients with cerebral infarction. The areas under the curves were 0.846, 0.764, and 0.688, respectively (P <0.001).Conclusions Serum MCP-1, MMP-9, and Cys-C levels can be used as indicators to effectively evaluate the prognosis of patients with cerebral infarction.Journal of International Neurology and Neurosurgery, 2021, 48(1): 59-62]

    表 4 MCP-1、MMP-9和Cys-C对脑梗死患者预后的评估价值分析Table 4
    表 2 不同预后患者血清MCP-1、MMP-9、Cys-C水平及NIHSS评分比较Table 2
    表 3 血清MCP-1、MMP-9、Cys-C水平与NIHSS评分的相关性分析Table 3
    图1 MCP-1、MMP-9和Cys-C对脑梗死患者不同预后预测价值的ROC曲线Fig.1
    表 1 两组患者临床基线资料比较Table 1
    参考文献
    相似文献
    引证文献
引用本文

石小翠,胡美云,杜寨,宋佳456.血清单核细胞趋化蛋白1、基质金属蛋白酶9及胱抑素C水平对脑梗死患者预后的评估价值[J].国际神经病学神经外科学杂志,2021,48(1):59-62111SHI Xiao-Cui, HU Mei-Yun, DU Zhai, SONG Jia222. Prognostic value of serum levels of monocyte chemotactic protein-1, matrix metalloproteinase-9, and cystatin C in patients with cerebral infarction[J]. Journal of International Neurology and Neurosurgery,2021,48(1):59-62

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2020-06-10
  • 最后修改日期:2020-12-21
  • 录用日期:
  • 在线发布日期: 2021-06-03
关闭
关闭